Successfully targeting the cancer system with metronomics for medulloblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successfully targeting the cancer system with metronomics for medulloblastoma

Published:2023-12 Issue:12 Volume:9 Page:989-991
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

André Nicolas^ORCID,Bailey Simon,Peyrl Andreas

Funder

INCa

Canceropôle PACA

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference10 articles.

1. Clinical trials in high-risk medulloblastoma: evolution of the SIOP-Europe HR-MB trial;Bailey;Cancers,2022

2. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus;Ramaswamy;Acta Neuropathol.,2016

3. AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial;Geoerger;Nat. Med.,2023

4. Multi-scale network targeting: a holistic systems-biology approach to cancer treatment;Paul;Prog. Biophys. Mol. Biol.,2021

5. Metronomic chemotherapy: direct targeting of cancer cells after all?;André;Trends Cancer,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP